BriaCell Therapeutics Corp. Common Shares (NASDAQ: BCTX)
$0.5346
-0.0365 ( -9.39% ) 753.5K
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Market Data
Open
$0.5346
Previous close
$0.5711
Volume
753.5K
Market cap
$24.99M
Day range
$0.5340 - $0.6050
52 week range
$0.4641 - $5.9700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 7 | Dec 17, 2024 |
| 8-k | 8K-related | 24 | Dec 16, 2024 |
| 10-q | Quarterly Reports | 65 | Dec 16, 2024 |
| 8-k | 8K-related | 27 | Dec 13, 2024 |
| 8-k | 8K-related | 14 | Nov 25, 2024 |
| 8-k | 8K-related | 28 | Nov 01, 2024 |
| 10-k | Annual reports | 104 | Oct 29, 2024 |
| 8-k | 8K-related | 26 | Oct 02, 2024 |
| 8-k | 8K-related | 18 | Oct 01, 2024 |
| 8-k | 8K-related | 24 | Sep 12, 2024 |